ReviewEndocrine, metabolic & immune disorders drug targets2025
Gut Microbiota and Diabetes: Pioneering New Treatment Frontiers.
Rupendra Shakya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it